Avidity Partners Management’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,040,000	Closed	-$19.2M	–	97
2022 Q1	$19.2M	Sell	1,040,000 -238,261	-19%	-$4.41M	0.4%	53
2021 Q4	$25.3M	Buy	+1,278,261	New	+$25.3M	0.54%	52